Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 R (Q33401216)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 R |
scientific article |
Statements
1 reference
Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 R (English)
1 reference
Christian Koenecke
1 reference
Alois Gratwohl
1 reference
Philippe Moreau
1 reference
Heinz Ludwig
1 reference
Dietger Niederwieser
1 reference
Laurent Garderet
1 reference
Mamoun Dib
1 reference
Jean Luc Harousseau
1 reference
Mohamad Mohty
1 reference
Chantal Doyen
1 reference
Nicolas Ketterer
1 reference
Ingrid Lafon
1 reference
Mauricette Michallet
1 reference
Roman Hajek
1 reference
Philippe Casassus
1 reference
Andrew Cakana
1 reference
Simona Iacobelli
1 reference
Jean Fontan
1 reference
Brigitte Kolb
1 reference
Bernd Hertenstein
1 reference
Francesco Onida
1 reference
Marleen van Os
1 reference
Norbert Claude Gorin
1 reference
Theo de Witte
1 reference
Curly Morris
1 reference
Gösta Gahrton
1 reference
14 May 2012
1 reference
1 reference
30
1 reference
20
1 reference
2475-2482
1 reference
Identifiers
1 reference
1 reference